Cave & Sons News & Articles

Welcome to our News and Articles Section. Please click on the links below to read more about that story.

Citywire Interview: My Asset Allocation - Cave & Sons CEO bullish on infrastructure trusts

July 9th, 2009

andy-cockerill

 

Andrew Cockerill, an investment manager at Northampton-based stockbroking firm Cave & Sons, remains unconvinced by talk of green shoots and a rapid economic recovery.

 

On this basis, he is backing defensive stocks.

 

Cockerill, who is chief executive at the firm, said: ‘We are still favouring defensives, particularly pharmaceuticals, telecoms and utilities, which are all offering above-average dividend yields and decent earnings visibility.’

 

He is also positive on investment trusts, having recently invested in 3i Infrastructure, capitalising on share price weakness following Saudi Saad Group’s decision to sell down its stake. Cockerill believes the trust looks like an ‘attractive long-term proposition’ and also has exposure to HSBC Infrastructure.

 

In addition, Cockerill is seeing value in the UK growth and income investment trust sector, pointing to the sector’s long track record of maintaining dividend yields.

 

For international exposure, Cockerill is backing Alliance Trust, Monks IT and Murray International, alongside Investec Global Free Enterprise and the Threadneedle Global Select funds.

 

Cockerill favours corporate bond funds over conventional gilts, having moved into the asset class nine months ago. ‘We are also interested in index-linked gilts as a longer term inflation hedge,’ he added.

 

 

 

Understanding Rights Issues

July 1st, 2009

With many companies choosing to use rights issues as a method of raising additional capital in the current economic climate, we felt it beneficial to produce a handy guide on the subject.

The guide aims to increase understanding about what a rights issue entails and explains the options available to shareholders in the event of one being undertaken by a firm in which you hold shares.

Please click HERE or go to the downloads section of the website to view the guide

.

 

Caves Open New Stockbroking and Investment Office in Leicester

June 18th, 2009

 

 paul-murray-with-simon-harvey-l-andrew-cockerill

 

 

Local investment management and stockbroking group Cave & Sons has opened a new office in Leicester, expanding its Midlands presence. Established in 1906, Cave & Sons has been providing investment management and traditional stockbroking services for over a century.

 

The company, which already has offices in Northampton and Stratford Upon Avon, will now have a presence in the centre of Leicester, helping the company boost its regional, national and international client base yet further.

 

Northampton based Simon Harvey, who is Cave & Sons Head of Stockbroking and Investment Management, is delighted with the company’s expansion.

 

“Opening a new office in Leicester shows our commitment to strengthening our position in the region and building on our existing presence,” said Simon. “From our existing offices in Northampton and Stratford upon Avon we work with individual clients directly and through professional connections such as Financial Advisers, Solicitors and Accountants.

 

“A truly independent company, established for over a century, with highly qualified staff and a flexible approach is a winning formula and will be of significant benefit to Leicester’s individual investors and professional connections alike.”

 

Paul Murray 45, who will be heading up the Leicester operation commented: “I am delighted to be joining Cave & Sons, a fantastic company with an excellent support network and a remarkable history.  I share a similar philosophy to the existing management, with a strong belief in offering both exceptional customer service and value.

 

“The independent nature of Cave & Sons means that there are no external influences being brought to bear and all clients can be treated as individuals and according to their needs.  By joining Cave & Sons I look forward to expanding my client base further and continuing to offer all of my clients the personal approach that they are used to.”

 

 If Paul or his team can be of any assistance, please do not hesitate to contact them on 0116 271 7210

Investment Review - Summer 2009

June 15th, 2009

Please click below to view our latest Investment Review

Investment Review Summer 2009

Swine Flu - Which parts of the market are prone to infection?

May 18th, 2009

 

Swine Flu – Which parts of the market are prone to infection?

Just as risk appetite was returning to global financial markets, the last thing we need is a potential global flu pandemic. At present there are still many more questions than answers (how infectious, how deadly?) and it seems unlikely that these can be answered quickly, further denting the already tentative return of investor confidence.

Whilst it’s imperative not to panic, we feel it’s also important for investors to quickly evaluate how the potential pandemic may affect financial markets and prepare for the different eventualities. One way to consider the possible effects is to draw comparisons from the way the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS) affected markets. Although SARS never materialised as a global pandemic, it lasted six months and killed 775 of the 8,000 people infected across 25 countries.  

The four main economies affected by the SARS outbreak were China, Hong Kong, Taiwan and Singapore. At a macroeconomic level, the GDP shock was relatively short lived; all four saw dips in quarterly figures, but growth rates soon rebounded in the following quarters as it became apparent that the outbreak was under control. However, as you might expect, performances across economic sectors and individual companies varied widely. The most severely affected areas were Hotels, Air Transport, Restaurants, Retail and Land Transport which experienced a direct and immediate curtailment in spending and economic activity. There were also some sectors which benefited from the outbreak, all health related, with Pharmaceuticals, Diagnostic Laboratories, Vaccine Development and Hospital/Essential Services sectors all benefiting.

So what individual UK companies can we expect to be affected from the recent swine flu outbreak? Early indications are that trends are following a similar pattern to that of SARS, although it must be remembered that SARS was a relatively well contained outbreak and never developed into a pandemic, with international trade and foreign direct investment largely unaffected. This time, the authorities seem convinced that the risks are greater, particularly as we move closer to our flu season later in the year and if, as predicted, the swine flu virus mutates into a more virulent strain. When news of the first swine flu cases broke, Airline and Travel/Tourism related stocks all suffered. British Airways, InterContinental Hotels, TUI, Thomas Cook and cruise company Carnival were amongst the biggest losers in the FTSE. As one might expect, based on past experience, the pharmaceutical firms GlaxoSmithKline, AstraZeneca and Shire all rose, buoyed by the drug makers assurances that they could supply millions of doses of medicine and were ready to work on a vaccine against swine flu.   

The severity of the outbreak will determine how wide the shock waves run. So far the areas affected have been confined to those directly influenced, but this will change rapidly if a pandemic is confirmed and fear spreads that it will prolong or hamper the recovery in the beleaguered world economy.  Moody’s, the credit ratings agency, estimates that a global pandemic could knock 0.8% off global GDP in the coming year. A significant effect on an already struggling world economy which could forestall any economic recovery for the time being.

It is possible to see how a broader range of individual companies could be affected, if the pandemic develops with Mexico having already enforced the closure of restaurants, cinemas and the like. UK Pub companies, Leisure stocks and Retailers could all suffer if we get to the stage of limiting public gathering. Thankfully, at present, this seems some way off; so far only one death from the virus has been confirmed outside of Mexico, those infected in the rest of the world have suffered only mild symptoms and transmission rates appear low. However, as always, it’s worth being prepared.

 

© Copyright 2010 - Cave and Sons - All Rights Reserved - W3C Compliant XHTML - W3C Compliant CSS - Web Design & SEO by Creare

Authorised and Regulated by the Financial Services Authority. Member of the London Stock Exchange and A.P.C.I.M.S. FSA Number 143715.
Registered Office: Cave & Sons Ltd, Lockgates House, Rushmills, Northampton, NN4 7YB. Registered in England Number 1916615. VAT Reg No 443759132.